CHICAGO, July 11,
2024 /PRNewswire/ -- Medical professionals and
students alike are gearing up for an unparalleled opportunity to
delve into the latest advancements in thyroid care at the 2024
Master Course of Thyroid Radiofrequency Ablation (MCTR), taking
place on August 10th at the Warwick
Allerton Hotel in Chicago, IL.
Hosted by STARmed America and directed by thyroid RFA pioneer,
Dr. Jung Hwan Baek, this one-day
intensive course promises to be a transformative experience for
attendees. The event will feature hands-on workshops, didactic
lectures, and insights from global leaders in thyroid
radiofrequency ablation (RFA).
"We are excited to bring together experts and learners to
explore innovative approaches in thyroid RFA," said Dr. Baek. "This
course is designed to equip participants with practical skills and
knowledge that can directly impact patient care."
Participants will have the opportunity to interact with peers
and mentors, enhancing their understanding of thyroid nodule
management and treatment options. The comprehensive curriculum
covers a wide range of topics including, thyroid RFA guidelines,
RFA for thyroid cancer and indeterminant nodules, preventing nodule
regrowth and interesting case discussions.
One of the highlights of the event is the complimentary firework
cruise dinner on Lake Michigan,
providing a picturesque backdrop for networking and relaxation
after a day of intensive learning.
"We encourage physicians and medical students and residents from
across the world to join us," added Dr. Baek. "Whether you are new
to thyroid RFA or seeking to refine your skills, this course offers
something for everyone."
Spaces are limited, and interested individuals are encouraged to
register early to secure their spot. For more information and to
register, visit MCTR 2024 Event Page or contact
info@STARmed-America.com.
Don't miss out on this exceptional opportunity to advance your
knowledge and skills in thyroid care. Join us at the 2024 MCTR and
be part of shaping the future of thyroid RFA.
About STARmed America
STARmed America is a South Korean-based medical device
manufacturer specializing in thermal ablation technology. Focused
on radiofrequency ablation generators and electrodes, STARmed
America is globally recognized for innovative solutions and
improving patient outcomes. As the first company in the world to
innovate radiofrequency ablation technology for thyroid nodules,
STARmed boasts over 15 years of research and innovation in thyroid
RFA. STARmed's radiofrequency ablation (RF) equipment is utilized
by more than 80% clinical articles, underscoring our efficacy
in thyroid nodule management. For more information, visit
www.STARmed-America.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/explore-cutting-edge-techniques-in-thyroid-care-at-the-2024-master-course-of-thyroid-radiofrequency-ablation-302194112.html
SOURCE STARmed America Inc.